-
Je něco špatně v tomto záznamu ?
The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions
Jan Miroslav Hartinger, Eliska Dvorackova, Marek Myslivecek, Zdenka Hruskova, Martin Satny, Lukas Zlatohlavek, Jarmila Krizova, Martin Sima, Vladimir Tesar, Ondrej Slanar
Status minimální Jazyk angličtina Země Slovensko
OBJECTIVES: Ciprofloxacin induces rare neuro-psychiatric adverse drug reactions (ADRs) that are, as yet, not possible to predict due to unknown predisposition factors. BACKGROUND: The aim of the analysis was to assess the frequency of neuro-psychiatric ADRs and to identify potential risk factors that predisposed patients to ciprofloxacin neurotoxicity. METHODS: This observational retrospective study involved the evaluation of the medical records of patients in the Nephrology department and 3rd Internal Clinic of the General University Hospital in Prague. RESULTS: The overall incidence of neurological ADRs was 3.6 %. No neurological ADRs developed in patients aged less than 70 years. The covariates that were significantly more prevalent in the patients who developed neuropsychiatric ADRs were as follows: higher age, a history of neuropsychiatric disorders and the use of anticonvulsants. The administration of drugs from other ATC groups, gender, weight, body mass index, body surface area, renal functions, level of C-reactive protein at the beginning of treatment and the total daily dose/kg did not differ significantly between the two groups. CONCLUSION: Ciprofloxacin neuropsychiatric ADRs are more frequent in older patients with a history of neurologic or psychiatric disorders. No other tested covariates were proven to predispose patients to neuropsychiatric ADRs during treatment with ciprofloxacin (Tab. 2, Ref. 20).
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23023231
- 003
- CZ-PrNML
- 005
- 20240110150351.0
- 007
- ta
- 008
- 240110s2023 xo f 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2023_120 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Hartinger, Jan $7 xx0224709 $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 245 14
- $a The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions / $c Jan Miroslav Hartinger, Eliska Dvorackova, Marek Myslivecek, Zdenka Hruskova, Martin Satny, Lukas Zlatohlavek, Jarmila Krizova, Martin Sima, Vladimir Tesar, Ondrej Slanar
- 504 __
- $a Literatura
- 520 9_
- $a OBJECTIVES: Ciprofloxacin induces rare neuro-psychiatric adverse drug reactions (ADRs) that are, as yet, not possible to predict due to unknown predisposition factors. BACKGROUND: The aim of the analysis was to assess the frequency of neuro-psychiatric ADRs and to identify potential risk factors that predisposed patients to ciprofloxacin neurotoxicity. METHODS: This observational retrospective study involved the evaluation of the medical records of patients in the Nephrology department and 3rd Internal Clinic of the General University Hospital in Prague. RESULTS: The overall incidence of neurological ADRs was 3.6 %. No neurological ADRs developed in patients aged less than 70 years. The covariates that were significantly more prevalent in the patients who developed neuropsychiatric ADRs were as follows: higher age, a history of neuropsychiatric disorders and the use of anticonvulsants. The administration of drugs from other ATC groups, gender, weight, body mass index, body surface area, renal functions, level of C-reactive protein at the beginning of treatment and the total daily dose/kg did not differ significantly between the two groups. CONCLUSION: Ciprofloxacin neuropsychiatric ADRs are more frequent in older patients with a history of neurologic or psychiatric disorders. No other tested covariates were proven to predispose patients to neuropsychiatric ADRs during treatment with ciprofloxacin (Tab. 2, Ref. 20).
- 700 1_
- $a Dvořáčková, Eliška $7 kv2015890922 $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Mysliveček, Marek $7 xx0237858 $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Hrušková, Zdeňka $7 xx0146108 $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Šatný, Martin $7 xx0227681 $u Third Internal Department of Endocrinology and Metabolism, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Zlatohlávek, Lukáš, $d 1978- $7 xx0061418 $u Third Internal Department of Endocrinology and Metabolism, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Křížová, Jarmila $7 xx0017659 $u Third Internal Department of Endocrinology and Metabolism, Charles University and General University Hospital, Prague, Czech Republic
- 700 1_
- $a Šíma, Martin $7 xx0222901 $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Tesař, Vladimír, $d 1957- $7 jn20000402349 $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 700 1_
- $a Slanař, Ondřej $7 xx0058262 $u Department of Pharmacology, First Faculty of Medicine, Charles University and General University Hospital Prague, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 124, č. 10 (2023), s. 779-782 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=8134&session_id=7cmce1hbsfsdgujb6b93572nv2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 4 $c 1067 $y 0 $z 0
- 990 __
- $a 20240109132428 $b ABA008
- 991 __
- $a 20240110150347 $b ABA008
- 999 __
- $a min $b bmc $g 2033709 $s 1209682
- BAS __
- $a 3
- BMC __
- $a 2023 $b 124 $c 10 $d 779-782 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845 $n Bratisl Lek Listy
- LZP __
- $a NLK 2024-02/kv
